Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan S Berek

Showing results (31-40 of 137) with videos related to

Pageof 14
Sort By:
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|October 12, 2018
Cancer of the ovary, fallopian tube, and peritoneumJonathan S Berek, Sean T Kehoe, Lalit Kumar, et al.
Gynecologic Oncology|February 7, 2008
HER-2/neu targeting for recurrent vulvar Paget's disease A case report and literature reviewAmer Karam, Jonathan S Berek, Amy Stenson, et al.
Gynecologic Oncology|August 2, 2005
Pelvic exenteration for recurrent gynecologic malignancy: survival and morbidity analysis of the 45-year experience at UCLAJonathan S Berek, Candace Howe, Leo D Lagasse, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|October 20, 2021
Cancer of the ovary, fallopian tube, and peritoneum: 2021 updateJonathan S Berek, Malte Renz, Sean Kehoe, et al.
Journal of Global Oncology|July 20, 2017
Reply to B.O. Anderson et alLinus T Chuang, Nagi S El Saghir, Sarah Temin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 7, 2016
Management and Care of Women With Invasive Cervical Cancer: ASCO Resource-Stratified Clinical Practice GuidelineLinus T Chuang, Sarah Feldman, Carolyn Nakisige, et al.
Obstetrics and Gynecology|December 22, 2016
Salpingo-Oophorectomy at the Time of Benign Hysterectomy: A Systematic ReviewWilliam H Parker, Michael S Broder, Jonathan S Berek, et al.
American Journal of Obstetrics and Gynecology|January 19, 2010
Toll-like receptor-3 as a target to enhance bioactivity of cancer immunotherapyChristopher F Nicodemus, Lin Wang, Julie Lucas, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|May 10, 2024
Contraceptive strategies for reducing the risk of reproductive cancersA R Aliabadi, Sarikapan Wilailak, Orla McNally, et al.
International Journal of Oncology|August 7, 2014
Auranofin displays anticancer activity against ovarian cancer cells through FOXO3 activation independent of p53See-Hyoung Park, Jung Han Lee, Jonathan S Berek, et al.
Pageof 14

Showing results (31-40 of 137) with videos related to

Sort By:
Pageof 14
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|October 12, 2018
Cancer of the ovary, fallopian tube, and peritoneumJonathan S Berek, Sean T Kehoe, Lalit Kumar, et al.
Gynecologic Oncology|February 7, 2008
HER-2/neu targeting for recurrent vulvar Paget's disease A case report and literature reviewAmer Karam, Jonathan S Berek, Amy Stenson, et al.
Gynecologic Oncology|August 2, 2005
Pelvic exenteration for recurrent gynecologic malignancy: survival and morbidity analysis of the 45-year experience at UCLAJonathan S Berek, Candace Howe, Leo D Lagasse, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|October 20, 2021
Cancer of the ovary, fallopian tube, and peritoneum: 2021 updateJonathan S Berek, Malte Renz, Sean Kehoe, et al.
Journal of Global Oncology|July 20, 2017
Reply to B.O. Anderson et alLinus T Chuang, Nagi S El Saghir, Sarah Temin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 7, 2016
Management and Care of Women With Invasive Cervical Cancer: ASCO Resource-Stratified Clinical Practice GuidelineLinus T Chuang, Sarah Feldman, Carolyn Nakisige, et al.
Obstetrics and Gynecology|December 22, 2016
Salpingo-Oophorectomy at the Time of Benign Hysterectomy: A Systematic ReviewWilliam H Parker, Michael S Broder, Jonathan S Berek, et al.
American Journal of Obstetrics and Gynecology|January 19, 2010
Toll-like receptor-3 as a target to enhance bioactivity of cancer immunotherapyChristopher F Nicodemus, Lin Wang, Julie Lucas, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|May 10, 2024
Contraceptive strategies for reducing the risk of reproductive cancersA R Aliabadi, Sarikapan Wilailak, Orla McNally, et al.
International Journal of Oncology|August 7, 2014
Auranofin displays anticancer activity against ovarian cancer cells through FOXO3 activation independent of p53See-Hyoung Park, Jung Han Lee, Jonathan S Berek, et al.
Pageof 14